ArticleBlood advances2021

Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax.

Curtis A Lachowiez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.